Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish

Graphene is an attractive choice for the development of an effective drug carrier in cancer treatment due to its high adsorption area and pH-responsive drug affinity. In combination with the highly potent metabolic drug phenformin, increased doses could be efficiently delivered to cancer cells. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhourani, Abdelnour, Førde, Jan-Lukas, Nasrollahzadeh, Mojdeh, Eichacker, Lutz Andreas, Herfindal, Lars, Hagland, Hanne Røland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417205/
https://www.ncbi.nlm.nih.gov/pubmed/36134366
http://dx.doi.org/10.1039/d1na00778e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417205/
https://www.ncbi.nlm.nih.gov/pubmed/36134366
http://dx.doi.org/10.1039/d1na00778e

Ejemplares similares